forced BE? [Design Issues]

posted by ElMaestro  – Denmark, 2017-08-07 15:44 (2746 d 16:48 ago) – Posting: # 17668
Views: 16,130

Hi Hötzi,

❝ (blahblah) The basis of these estimates should also be given. It is important to investigate the sensitivity of the sample size estimate to a variety of deviations from these assumptions and this may be facilitated by providing a range of sample sizes appropriate for a reasonable range of deviations from assumptions. In confirmatory trials, assumptions should normally be based on published data or on the results of earlier trials.


Yessir!!!!!!!!
Thanks for bringing it up.

That is indeed why we need to apply more bootstrapping in BE.

It, too, tells what sample size we need, but in contrast to ordinary power calcs it allows one to take into account that residuals may not be normal even though the evaluation itself makes that assumption. And that is a story for another day.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
28 visitors (0 registered, 28 guests [including 4 identified bots]).
Forum time: 07:33 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5